Antagonist treatment of opioid withdrawal translational low dose approach.

Published

Journal Article (Review)

Although antagonist drugs are receiving increasing attention in the treatment of opioid withdrawal, the mechanisms of interaction of opiate agonists and antagonists remain largely to be investigated. We focused on the effects of very low quantities of opiate antagonists, following the clinical indication of their potential utility in detoxification. Upon reviewing the evidence on the administration of small doses of naloxone and naltrexone in the presence of agonist drugs, the effects of low-dose naltrexone during opiate administration and withdrawal are described. The application of a translational methodology allowed completing the clinical design with behavioral and cellular information obtained from a specifically developed animal model. The initial results indicate that low doses of naltrexone may help reducing the manifestation of opioid withdrawal, offer suggestions for further investigations and confirm the utility of a translational research approach to the clinical neurobiology of drug addiction.

Full Text

Duke Authors

Cited Authors

  • Mannelli, P; Gottheil, E; Van Bockstaele, EJ

Published Date

  • 2006

Published In

Volume / Issue

  • 25 / 2

Start / End Page

  • 1 - 8

PubMed ID

  • 16785213

Pubmed Central ID

  • 16785213

International Standard Serial Number (ISSN)

  • 1055-0887

Digital Object Identifier (DOI)

  • 10.1300/J069v25n02_01

Language

  • eng

Conference Location

  • England